Meriam Kabbaj
Technik-/Wissenschafts-/F&E-Leiter bei GENFIT
Profil
Meriam Kabbaj has founded Versantis AG in 2015, where she holds the title of Chief Operating Officer & Director.
She is currently the Chief Technology Officer at Genfit SA since 2022.
Dr. Kabbaj has a doctorate degree from the University of Montréal.
Aktive Positionen von Meriam Kabbaj
| Unternehmen | Position | Beginn |
|---|---|---|
| GENFIT | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Gründer | 01.01.2015 |
Ausbildung von Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENFIT | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
